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Abstract
Background: Despite no demonstrated survival advantage for women at average risk of breast cancer, rates of
contralateral prophylactic mastectomy (CPM) continue to increase. Research reveals women with higher
socioeconomic status (SES) are more likely to select CPM. This study examines how indicators of SES, age, and
disease severity affect CPM motivations.
Methods: Patients (N = 113) who underwent CPM at four Indiana University affiliated hospitals completed
telephone interviews in 2013. Participants answered questions about 11 CPM motivations and provided
demographic information. Responses to motivation items were factor analyzed, resulting in 4 motivational factors:
reducing long-term risk, symmetry, avoiding future medical visits, and avoiding treatments.
Results: Across demographic differences, reducing long-term risk was the strongest CPM motivation. Lower income
predicted stronger motivation to reduce long-term risk and avoid treatment. Older participants were more
motivated to avoid treatment; younger and more-educated patients were more concerned about symmetry.
Greater severity of diagnosis predicted avoiding treatments.
Conclusions: Reducing long-term risk is the primary motivation across groups, but there are also notable
differences as a function of age, education, income, and disease severity. To stop the trend of increasing CPM,
physicians must tailor patient counseling to address motivations that are consistent across patient populations and
those that vary between populations.
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Background
Despite the lack of a demonstrated survival advantage,
the rate of contralateral prophylactic mastectomy (CPM)
for the treatment of unilateral breast cancer in women
without a genetic predisposition for the development of
breast cancer continues to increase unabatedly [1–7]. In-
creasing use of this procedure contradicts expert med-
ical recommendations, such as those of The National
Comprehensive Cancer Network; indeed, it has been
estimated that fewer than 10% of women with newly di-
agnosed breast cancer meet the clinical criteria for CPM
[8]. Reversing this trend requires that we understand
why women are choosing CPM.
A 2011 survey of CPM-related research noted that
women’s reasons for electing CPM were poorly under-
stood [9]. Research conducted in the interim indicates
that women choosing CPM are not being influenced by
the medical evidence demonstrating no survival advan-
tage [8, 10, 11]. Instead, substantial numbers of women
believe they are at considerable risk of a new contralat-
eral primary, and CPM improves their likelihood of
survival [10, 11]. Even in the extreme case of the diag-
nosis of ductal carcinoma in situ (DCIS, Stage 0) this
holds true. Breast cancer specific survival for women
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diagnosed with DCIS and treated by breast conservation
or unilateral mastectomy is on the order of 99% at 20 years
[12]. Nevertheless, SEER data documents an increase in
CPM for DCIS patients from 12.7% in 1998 to 36.5% of
cases in 2011 [13]. Patients also report seeking CPM to
avoid subsequent medical visits and treatments (e.g., sur-
gery, chemotherapy, medications), and to retain/obtain a
symmetrical appearance [10, 11, 14–16].
At the same time, it is clear that the choice of CPM is
not uniform across groups of women in the United
States. Data from the National Cancer Data Base [17]
and the Florida Cancer Data System [18], show that
higher socioeconomic status (SES) and private insurance
are positively associated with undergoing CPM. Corres-
pondingly, White women undergo CPM at a rate at least
twice that of Black women [8]. These factors may be
proxies for access to all forms of medical care, but they
also may represent variation in sources of information
about cancer, differing levels of concern about body
image, or differing risk perceptions [19, 20]. For ex-
ample, multiple studies have shown that White women
are more likely than other racial groups to overestimate
their risk of developing breast cancer [21, 22]. Another
demographic associated with higher CPM rates is young
age at diagnosis [23–25]. The decision of younger pa-
tients to avail themselves of CPM has been attributed to
the expectation of a long life following the initial diagno-
sis with a consequently higher lifetime risk of developing
another primary breast cancer [15, 23]. Most prior
studies of reasons for CPM have focused on small sub-
sets of possible motivations [8, 26], often reporting per-
centages of patients experiencing particular motivations
or concerns [11]. Alternatively, qualitative studies have
explored patients verbatim explanations about the fac-
tors that influenced them [10]. Such studies have not
directly addressed variation in motivations among pa-
tients with different socioeconomic and demographic
characteristics. To remedy limitations in the existing
research and provide additional insights into CPM deci-
sion making, this study addresses the following research
questions: (1) What personal motivations for seeking
CPM are stronger or weaker overall, and (2) to what ex-
tent does their importance for women vary as a function
of education, employment, income, insurance status,
race, age, and disease severity?
Methods
Ethics
This study was approved by the Indiana University Insti-
tutional Review Board (IRB-04, protocol number
1210009689; and IRB-03, protocol number 1304011094).
All research was carried out in compliance with the
Helsinki Declaration.
Questionnaire development
The literature was consulted in order to create questions
that would adequately represent the range of patient
motivations for CPM [10, 11, 14–16]. Draft versions of
the questionnaire were piloted with four focus groups of
five individuals each; one group consisted of lay individ-
uals, one of physicians practicing non-surgical special-
ties, and two of the focus groups were made up of breast
patients with five breast cancer survivors divided between
these two groups. Based on their input, the questionnaire
was modified by replacing scientific/medical terms with
their lay equivalents, and removing what participants
considered to be leading questions and questions that
elicited a significant emotional response. The question-
naire is provided in Additional file 1.
Data collection
This study was facilitated by access to patients who
underwent CPM at four hospitals in Indianapolis, all of
which are teaching institutions within the Indiana Uni-
versity School of Medicine. Wishard Memorial Hospital
(now known as The Sidney and Lois Eskenazi Hospital)
is a large public safety net hospital, with a patient popu-
lation approximately equally divided between Black and
non-Hispanic White individuals; most are underinsured.
IU Health University Hospital is a tertiary referral center
at which many patients have private health insurance. IU
Health North and IU Health West are community
hospitals. The same surgeons staffed the breast surgical
oncology clinics at all four hospitals during the period of
this study, helping to ensure that surgeon effects on
CPM motivations and decisions were relatively constant
across the sample.
Potential participants for this study were identified
from hospital billing records using the procedure code
for bilateral mastectomy during the years 2008–2012.
The lists were then curated to identify patients who had
undergone CPM (n = 326). Patients’ names, addresses,
telephone numbers and the hospitals at which CPM was
performed were obtained from the medical health record
system. Approximately one-half of the patients were
treated at IU Health University Hospital, slightly over a
quarter at IU Health North and the remaining patients
divided between IU Health West and Wishard. During
2013, these patients received a mailed introductory letter
containing study information. Research team members
included faculty, residents, and graduate students, all
trained in research ethics and study procedures. Team
members telephoned participants, obtained their verbal
informed consent, and conducted structured interviews
using the motivations questionnaire (n = 117) along with
obtaining qualitative data that included brief narratives
of their breast cancer experience (reported in [27]). Only
16 patients contacted were recorded as explicitly
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refusing the interview and information about these pa-
tients was not retained. These 16 patients declined par-
ticipation for a variety of reasons. Some were still
undergoing treatment and reported they were too emo-
tionally “raw” to discuss their CPM decisions, some had
experienced subsequent disease progression, and others
wished not to revisit their illness. Other nonparticipation
resulted from inability to reach patients at the phone
numbers in their records.
Study population
Patients who elected CPM to treat unilateral breast can-
cer completed a structured telephone interview. Partici-
pant demographics reflect participant status at the time
of the surgery, and details are reported in Table 1. All
participants were women, with an average age at diagno-
sis of 50, predominantly married and employed. A ma-
jority had private insurance; education and income
varied. Most participants (n = 99, 88%) identified as
White, with the remainder Black (n = 12, 11%) and His-
panic (n = 2, 1.8%). The average time between CPM sur-
gery and survey completion ranged from 1 to 5 years,
M = 3.07, SD = 2.26. Patient-reported diagnoses included
invasive ductal cancer (n = 31, 27.4%), invasive cancer
(n = 26, 23%), ductal carcinoma in situ (n = 23, 20.4%),
mass/lump (n = 11, 8%), and other (n = 13, 11.5%).
When describing their breast cancer experiences, four
participants initially diagnosed prior to 2008 reported
having had a CPM following a local recurrence. Four
other patients self-identified as BRCA positive, and
their data was removed from analysis because this
suggests that CPM was medically indicated, changing
the nature of the decision-making process.
Given the sample size, the variables of interest were
dichotomized for analysis. Sample sizes for dichotomized
groups are reported in Table 1. Using the dichotomiza-
tion of Grimmer et al. [17], patients aged 45 or younger
were classified as younger, with patients 46 and above
classified as older. Patients who reported their diagnoses
as invasive (ductal, lobular, or other) were classified as
having more severe diagnoses, whereas patients with
other diagnoses (e.g., DCIS, mass/lump, mammogram
abnormality) were classified as having less severe diag-
noses. Patients were also grouped into less educated
(had not attained a bachelor’s degree) and more edu-
cated (bachelor’s or higher), and paid or unpaid work. A
lower income group was created from patients who indi-
cated that their income was in the categories 0-$25 K or
25 K–50 K; patients in any of the three higher-income
categories were similarly grouped together. Under-
insured patients were defined as all patients without
commercial insurance or HMO coverage. At the
Wishard and University Hospitals, such patients were
covered by Medicare, Medicaid, or the Wishard
Advantage assistance program. Wishard Advantage is
funded by taxes from Marion County, which includes
metropolitan Indianapolis, and helps provide coverage
for patients with limited financial resources who do not
qualify for Medicare or Medicaid. Race was classified as
minority (Black and Hispanic) or majority (White, non-
Hispanic). Because the number of minority participants
was small, resulting in problematic statistical power and
interpretation, we elected not to pursue our research
question with regard to race, and instead treated race as
a control variable in the subsequent analyses.
Study measures
Participants were asked to consider their experience of
11 motivations for undergoing CPM. These were (1) risk
reduction—belief that removing both breasts reduces
likelihood of cancer coming back, (2) recurrence-opposi-
te—concern that cancer would appear in the opposite
breast, (3) survival—belief that removing both breasts
increases the chance of long-term survival, (4) surger-
y—reduce or avoid need for later breast surgeries, (5)
symmetry—desire to maintain a symmetrical appearance,
(6) recurrence-distant—concern that cancer would
appear elsewhere in the body, (7) radiation—desire to
reduce or avoid need for radiation treatment, (8) proce-
dures—desire to reduce or avoid procedures such as
mammograms and MRIs, (9) chemotherapy—desire to
reduce or avoid chemotherapy, (10) physician visits–desire
to reduce or avoid future visits to the breast surgeon,
oncologist, or hospital, and (11) medications– desire to
reduce or avoid medications that block hormones. Each
motivation was assessed with a single-item measure, on a
scale from not at all (1) to a very large amount (5). Age at
diagnosis and diagnosis were assessed prior to the motiva-
tions; race, education, employment, income, and insur-
ance were assessed afterward.
To determine whether the 11 motivation items repre-
sented a smaller set of dimensions, the 11 items were
subjected to a principal components exploratory factor
analyses with varimax rotation, computed in SPSS 23.
Four factors were detected (all factor loadings > .76):
avoiding treatment, reducing long-term risk, avoiding fu-
ture visits, and symmetry. The avoiding treatment factor
was comprised of items on the desire to reduce or avoid
chemotherapy, radiation, and hormone blocking medica-
tion (λ = 2.22; α = .83, M = 2.14, SD = 1.28). The reducing
long-term risk factor was comprised of items on the de-
sire to avoid opposite breast new primary, risk reduction,
and survival (λ = 2.3; α = .85, M = 4.2, SD = 0.91). The
avoiding future visits factor was comprised of items on
the desire to avoid physician visits and procedures (λ =
1.69; α = .81, M = 2.24, SD = 1.24). The single symmetry
item loaded on its own factor (M = 3.42, SD = 1.44). Two
items, assessing the recurrence-distant and surgery
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motivations, did not load onto any factors and conse-
quently were not analyzed further.
Statistical analyses
Data was analyzed in three stages. The first stage exam-
ined the relative strength of CPM motivations for all
participants employing paired-sample t-tests. The sec-
ond stage examined relationships between dichotomized
predictor variables and CPM motivations, also using
paired sample t-tests. Finally, the third stage utilized
hierarchical multiple regression analyses to determine
which predictors had effects independent of the others.
For all analyses, unless otherwise specified, significance
is reported at p < .05.
Results
The first stage of the analysis examined the average en-
dorsement of each motivation in the total sample. There
was variation in the extent to which respondents en-
dorsed the 4 motivation factors for CPM, ranging from
strongest endorsement for reducing future risk (M = 4.2;
4 = a large amount) to weakest endorsement for avoiding
future visits (2.2; 2 = a small amount). A series of
paired-sample t tests revealed that the strength of redu-
cing future risk was significantly greater than the other
three motivations, and strength of symmetry was
Table 1 Participant characteristics
Diagnosis
Invasive ductal cancer (n = 31) 27.4%
Invasive cancer (n = 26) 23.0%
Ductal carcinoma in situ (n = 23) 20.4%
Mass/lump (n = 11) 9.7%
Invasive lobular cancer (n = 9) 8.0%
Other (n = 13) 11.5%
Diagnosis dichotomy (n = 113)
Less serious (n = 47) 41.6%
More serious (n = 66) 58.4%
Income
Less than 25 K (n = 7) 6.2%
25–50 K (n = 20) 17.7%
51–75 K (n = 25) 22.1%
76–100 K (n = 17) 15.0%
101 K (n = 30) 10.6%
Declined to Answer (n = 14) 12.3%
Income dichotomy (n = 99)
Less than 51 K (n = 27) 23.9%
51 K + (n = 72) 63.7%
Insurance
Private (n = 80) 71.4%
Medicare/Medicaid (n = 12) 10.8%
Other (n = 13) 11.5%
Declined to Answer (n = 7) 6.3%
Insurance dichotomy (n = 105)
Private (n = 80) 76.1%
Other (n = 25) 23.8%
Race/ethnicity
White (n = 99) 87.6%
Black (n = 12) 10.6%
Hispanic (n = 2) 1.8%
Race/ethnicity dichotomy
White (n = 99) 87.5%
Minority (n = 14) 12.5%
Marital status
Married/partnership (n = 86) 76.8%
Divorced/separated (n =12) 10.7%
Single (n = 8) 7.1%
Widowed (n = 6) 5.4%
Education
High school or less (n = 22) 19.5%
Some college (n = 36) 32.1%
Bachelor’s degree (n = 32) 28.6%
Graduate degree (n = 21) 18.8%
Table 1 Participant characteristics (Continued)
Declined to Answer (n = 2) 1.8%
Education dichotomy (n = 110)
Less than BA (n = 58) 51.3%
BA+ (n = 53) 46.9%
Employment status
Employed (n = 73) 64.6%
Retired (n = 18) 15.9%
Homemaker (n = 14) 12.4%
Unemployed (n = 4) 3.5%
Other (n = 1) 0.9%
Declined to Answer (n = 3) 1.8%
Employment dichotomy (n = 111)
Employed (n = 73) 64.6%
Unemployed (n = 37) 32.7%
Age at Diagnosis
Range 22-73, M = 50.29
SD = 12.50
Age dichotomy (n = 112)
Younger than 46 (n = 44) 38.9%
46 and older (n = 68) 61.1%
Note. N = 113, except as indicated
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significantly stronger than both avoiding treatment and
avoiding future visits. The strength of endorsement for
avoiding treatment and avoiding future visits was not
significantly different.
The second univariate stage of analysis compared the
endorsement of the four motivation factors for (1) less
severe versus more severe diagnosis, (2) younger versus
older, (3) less and more educated, (4) paid versus unpaid
employment, (5) lower and higher income, and (6) pri-
vate versus other insurance. Mean comparisons are
presented in Table 2. Respondents with a more severe
diagnosis endorsed avoiding treatment more strongly than
those with a less severe diagnosis (p < .01), and those with
a less severe diagnosis more strongly endorsed reducing
future risk (p = .06). Older respondents endorsed avoiding
treatment more strongly than younger respondents (p
< .01); younger respondents endorsed symmetry more
strongly than older respondents (p < .05). Compared to
less educated women, more educated women endorsed
symmetry (p < .01). Compared to women with paid em-
ployment, women without paid employment endorsed
avoiding treatment (p = .06). Women with less income en-
dorsed reducing future risk more strongly than did
women with more income (p < .01). Women with private
insurance did not differ from women with other forms of
insurance in their endorsement of any motivations. These
univariate differences had minimal effect on the order of
means across groups: across all demographics, reducing
long-term risk remained the highest, symmetry remained
the mid-rated reason, and avoiding treatment and avoid-
ing future visits remained low-rated reasons.
The third stage of analysis comprised a series of
hierarchical multiple regression analyses testing for the
independent effects of each predictor while controlling
for the effects of the other five demographic predictors
as well as participant race. This analysis was motivated
by the moderate correlations between most of the
predictor variables (see Table 3).
As shown in Table 4, avoiding treatment was predicted
by higher age (p < .05), lower income (p < .05), and more
severe diagnoses (p < .05). Reducing long-term risk was
predicted by lower income (p < .01), and symmetry was
predicted by higher education (p < .05). None of the pre-
dictors were significantly associated with avoiding future
visits. Effects in the univariate analyses that did not
achieve significance in the multiple regression analysis
indicate effects for one variable that do not persist when
the other predictor variables are controlled.
Discussion
This study shows statistically significant differences in CPM
motivations as a function of age, education, income, and se-
verity of diagnosis, but also shows considerable similarity in
the motivations that are most important to women. Across
socioeconomic differences, women participating in our
study rated reducing future risk (including survival and
avoiding a new primary in the non-involved breast) as the
most powerful motivation for their decision to elect CPM.
This pattern mirrors the results of several other stud-
ies showing that women’s foremost goal in choosing
CPM is improving their long-term outcomes [8, 11].
The consistency of this motivation across demographic cat-
egories underscores a set of interrelated problems. Women
perceive substantial risk from a new contralateral primary,
even though that risk is objectively low [11, 28–30]. Further,
they believe that CPM improves their long-term outcomes
even though the medical evidence does not support this be-
lief (except for women with BRCA mutations) [11]. Despite
socioeconomic diversity, which is proxy for participation in
different communities, exposure to different media, and dif-
ferent experiences with the health care system, breast can-
cer patients who choose CPM consistently express the
same primary, and erroneous, motivation. Correspondingly,
this study suggests that CPM patients are not responding
rationally to evidence-based recommendations for more
Table 2 Mean comparisons of participant demographics among CPM motivations
Patient Dichotomized Demographics
Diagnosis Age Education Employment Income Insurance
Less More Low High Low High No Yes Low High Public Private
CPM Motivations
Avoiding
Treatment
1.79
(1.15)
2.40 (1.30)** 1.76
(1.21)
2.38
(1.26)**
2.26
(1.26)
1.96
(1.21)
2.45
(1.32)
1.97
(1.18)†
2.46
(1.45)
2.08
(1.14)
1.81
(1.34)
2.16
(1.22)
Reducing
Long-term Risk
4.38
(.91)
4.06 (.89)† 4.31
(.84)
4.11
(.95)
4.19
(.91)
4.18
(.93)
3.99
(.87)
4.29
(.93)
4.52
(.67)
4.03
(.98)**
4.15
(.94)
4.27
(.89)
Avoiding
Future Visits
2.09
(1.36)
2.35 (1.14) 2.25
(1.30)
2.23
(1.21)
2.23
(1.10)
2.19
(1.35)
2.47
(1.09)
2.09
(1.27)
2.39
(1.09)
2.25
(1.27)
1.96
(1.15)
2.23
(1.26)
Symmetry 3.42
(1.53)
3.42 (1.39) 3.82
(1.42)
3.16
(1.41)*
3.05
(1.45)
3.77
(1.37)**
3.11
(1.37)
3.58
(1.45)
3.54
(1.70)
3.56
(1.27)
3.29
(1.71)
3.48
(1.41)
Means are presented and standard deviations are within parentheses. When relevant, significant mean differences are noted, ** p < .01, * p < .05, † p = .06
Baptiste et al. BMC Women's Health  (2017) 17:10 Page 5 of 9
conservative treatment—or that their surgeons are not
making those recommendations with sufficient strength.
In the context of this similarity, there were some
notable differences in CPM motivations as a function of
severity of diagnosis, income, age, and education.
Severity of diagnosis
Compared to patients less severe disease, patients
with invasive breast cancer were more motivated by
avoiding treatment. Although both invasive breast
cancers (more severe) and DCIS (less severe) can be
treated by breast conservation or mastectomy, only
patients with invasive disease will be offered chemo-
therapy and all of them will undergo some type of
lymph node surgery. Patients with invasive disease
face the prospect of more treatment over a longer
period of time and their rationale for choosing CPM
to avoid additional treatment seems to reflect this.
Patients treated for DCIS have a relatively short
course of treatment and thus their choice of CPM ap-
pears to depend more on wanting to avoid a new
breast neoplasm than on avoiding treatment.
Lower income
Controlling for education, employment, and insurance
(along with age, diagnosis, and race), lower income pre-
dicted stronger motivations for CPM based on both
long-term risk reduction and avoiding treatment. Thus,
these income effects are not best explained as resulting
from knowledge about breast cancer or CPM, or the dir-
ect costs of treatment, hospitalization, or surveillance. A
survey of the literature reveals a paucity of data on the
effects of a subsequent cancer diagnosis, i.e., recurrence
or new primary breast cancer, on low income individuals
and households. A possible explanation for the effect of
income on CPM decision-making is that because lower-
income women are essential to the financial stability of
their households, they are especially concerned about
the indirect costs of a new primary and associated treat-
ments. Lower-income women in paid employment often
have no sick leave; indeed, a 2015 report from the
Bureau of Labor Statistics estimates that 39% of the
private-sector workforce lacks paid sick days [31]. Unpaid
work days deprive families of funds for rent, utilities,
transportation, food and other critical expenses, and may
result in job loss [32, 33]. Even when lower-income
women do not work for pay, they often provide crucial do-
mestic labor (including childcare and eldercare) that al-
lows others to work outside the home [34, 35]. Thus,
independent of their education, insurance, or employ-
ment, low-income women may have personal incentives
to avoid time-consuming treatments for a contralateral
new primary that will require substantial time away from
normal activities for additional treatments. Since there
were no questions in our survey specifically directed to
concerns regarding lost jobs, lost income, or sick leave,
this explanation for the influence of income will have to
be directly tested in a future study.
Age and education
Prior studies have noted that concerns about symmetry
and the option for reconstruction prompt CPM [11, 23,
36, 37]. Indeed, King and colleagues found that patients
were more likely to select CPM instead of other surgical
options when they had strong symmetry concerns [37]. In
the current study, not only was symmetry motivation the
second-strongest, but patients who were younger and had
more education more strongly endorsed symmetry as a
motivation for CPM. The effect of age is consistent with
greater general concern for physical appearance in youn-
ger women [38] and with results recently reported by
Tesson and colleagues [39]. McLaren and Kuh’s analysis
of data from the Medical Research Council National
Table 4 Regression analysis of patient demographics and
disease severity predicting CPM motivations
CPM Motivations
Avoiding
treatment
Reducing
long-term risk
Avoiding
future visits
Symmetry
β t β t β t β t
Block 1
Race .07 .52 .13 1.29 −.05 −.49 .06 .58
Block 2
Race .13 1.24 .16 1.54 −.02 −.17 .06 .61
Age .23 2.21* −.08 −.78 −.04 −.39 −.13 −1.91
Education .003 .03 −.13 −1.19 .04 .37 .26 2.32*
Employment −.03 −.25 .17 1.58 −.15 −1.29 .14 1.23
Income −.23 −2.00* −.33 −2.84** −.05 −.41 −.09 −.75
Insurance .16 1.47 .15 1.35 .05 .42 −.06 −.51
Diagnosis .24 2.36* −.13 −1.31 .10 .92 .04 .40
Model
Adj. R2 .12 .09 −.04 .06
F 2.88** 2.33* .49 1.91
Note. *p < .05, p < .01**
Table 3 Correlations between dichotomized predictors
Age Diagnosis Education Employment Income
Age 1.00
Diagnosis −.16
Education −.30** .13
Employment −.28** −.02 .25**
Income −.03 .01 .28** .23*
Insurance .00 −.06 .25** .20* .43**
Note. *p < .05, p < .01**
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Survey of Health and Development suggests that appear-
ance esteem is more sensitive to education than to adult
occupationally-defined social class [40]. Correspondingly,
more highly-educated women may be more concerned
about the impact of breast cancer treatment on their
physical appearance. Consequently, with both younger
and more-educated women, physicians need to address al-
ternatives to CPM with greater attention to appearance-
related concerns.
Limitations
This study exhibits several limitations that should be
considered when interpreting our findings and conduct-
ing future research. Respondents self-reported their type
of breast neoplasm; the acquisition of clinical data re-
garding the patients’ tumors, stage of disease, receipt of
reconstruction, etc. was not a part of the approved
protocol. Additionally, we did not inquire as to the re-
spondents’ family history of breast cancer, number of
children or desire for future children, or the disease sta-
tus at the time of the interview. However, in a compan-
ion study to this one we did explore the influence of
family and friends treated for breast cancer on the deci-
sion to undergo CPM [27]. These or other factors might
explain greater variance in participants’ motivations than
we were able to explain. We also have no data on the
patients who we could not reach by telephone. The in-
ability to reach these potential participants may have in-
troduced bias into our sample. Further, our sample
included fewer ethnic minority participants than desired;
future prospective research efforts should consider col-
laboration with community leaders/groups to improve
participant diversity [41, 42]. We did not specifically
inquire as to BRCA 1/2 mutation carrier status, which
raises the possibility that there were more patients (other
than the four who identified themselves as carriers) that
should have been excluded as CPM would have been in-
dicated. Nonetheless, we believe this study adds import-
ant information relevant to the CPM debate. Most of the
data regarding SES and its impact on the choice of CPM
comes from large regional and national databases that
tell us who undergoes CPM but not why. By querying
women who chose CPM, we have obtained evidence that
the “why?” does not differ greatly as a function of SES:
patients are making many of the same assumptions
about CPM, survival, and new primary, and thus making
similar decisions.
Conclusion
In summary, the current study highlights both consistency
and variation in motivations for CPM—and points to the
complexity of intervening to halt the trend in selecting
this procedure. Across socioeconomic variation, women
who choose CPM are highly motivated by the desire to
reduce overall risk and risk of a new primary, and improve
survival. This is not surprising, since many women over-
estimate the risk of developing contralateral breast cancer
[14, 30]. Further, some women understand the relatively
small risk of recurrence but nonetheless prize the small
reduction in risk afforded by CPM [10, 11]. To help dis-
suade patients from CPM, physicians must provide careful
explanation that the risk of distant metastases from the
index lesion is much greater than the likelihood of a sec-
ond primary breast cancer [43], and that metastatic dis-
ease not a new primary, will be responsible for patient
death. There is a relatively robust portfolio of research on
the perceived risk of breast cancer as a function of demo-
graphic and psychological variables, which has been sum-
marized nicely in a meta-analysis by Katapodi and
colleagues [21] and revisited more recently by Orom et al.
[22]. Since statistical probabilities are often difficult for
patients to understand, physicians should consider using
visual aids that improve understanding of risk (e.g., depic-
tions of frequency of recurrence per 100 or 1000 patients)
[44]. Physicians also need to ensure that patients under-
stand the potential adverse effects of CPM [45]. And, they
need to help patients reduce the anxiety that contributes
to exaggerated perceptions of risk and leads to surgical de-
cisions that will not affect their survival [11, 43, 46].
Women also choose CPM to avoid to avoid breast asym-
metry. A symmetrical appearance is an understandable
goal, so physicians need to help patients realize that CPM
is not necessary to achieve it. Finally, guiding treatment
decisions for lower-income women may require that
physicians compassionately address the tension between
the minimal likelihood of a new primary and the real
economic implications if it occurs.
Additional file
Additional file 1: CPM Questionnaire. Questionnaire utilized to collect
data for this study. (PDF 760 kb)
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